KK
About
Kevin Koch is based out of Boulder, Colorado and is the President and CEO of Edgewise Therapeutics. Kevin previously worked at Biogen as a Senior Vice President, Drug Discovery, Chemical & Molecular Therapeutics. Kevin Koch attended State University of New York, Stony Brook.
Position in the VCSift Database
- • 29 investors at OrbiMed are tracked.
- • 421 investors hold the Venture Partner role in VCSift. Kevin Koch is one of them.
- • 266 investors are based in Boulder, Colorado, United States.
Data sourced from 410,343 investor profiles. Updated May 2026.
Investment Focus
- Location
- Boulder, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Kevin
Search Investors